Holen Sie sich die Stockscreener-App
7.41
4.63%
-0.36
Handel nachbörslich:
7.41
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BHC?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$7.77
Offen:
$7.77
24-Stunden-Volumen:
1.66M
Relative Volume:
0.67
Marktkapitalisierung:
$2.75B
Einnahmen:
$9.47B
Nettoeinkommen (Verlust:
$-178.00M
KGV:
-15.44
EPS:
-0.48
Netto-Cashflow:
$1.01B
1W Leistung:
+2.77%
1M Leistung:
+8.97%
6M Leistung:
+12.44%
1J Leistung:
-5.36%
1-Tages-Spanne:
$7.41
$7.89
1-Wochen-Bereich:
$7.16
$8.00
52-Wochen-Spanne:
$4.25
$8.685
Bausch Health Companies Inc Stock (BHC) Company Profile
Firmenname
Bausch Health Companies Inc
Sektor
Telefon
514-744-6792
Adresse
2150 ST. ELZEAR BLVD. WEST, QUEBEC, QC
Vergleichen Sie BHC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BHC
Bausch Health Companies Inc
|
7.41 | 2.88B | 9.47B | -178.00M | 1.01B | -0.48 |
|
ZTS
Zoetis Inc
|
127.17 | 55.90B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
16.31 | 51.72B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.91 | 44.71B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.01 | 37.30B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
RGC
Regencell Bioscience Holdings Ltd
|
45.79 | 20.48B | 0 | -5.87M | -767.30K | -0.45 |
Bausch Health Companies Inc Stock (BHC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Eingeleitet | Barclays | Equal Weight |
| 2024-08-02 | Herabstufung | Piper Sandler | Neutral → Underweight |
| 2024-07-10 | Eingeleitet | Raymond James | Mkt Perform |
| 2023-09-20 | Hochstufung | Jefferies | Hold → Buy |
| 2023-06-16 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2022-07-29 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-07-29 | Herabstufung | Truist | Buy → Hold |
| 2022-07-28 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-06-13 | Fortgesetzt | JP Morgan | Overweight |
| 2021-03-24 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-02-17 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2021-01-22 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-09-17 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2020-08-24 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-17 | Bestätigt | H.C. Wainwright | Buy |
| 2020-04-24 | Eingeleitet | Citigroup | Buy |
| 2020-04-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-29 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-01-22 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2019-12-12 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2019-12-02 | Eingeleitet | Goldman | Neutral |
| 2019-10-25 | Eingeleitet | Cowen | Outperform |
| 2019-09-12 | Eingeleitet | Guggenheim | Buy |
| 2019-08-15 | Hochstufung | TD Securities | Hold → Buy |
| 2019-07-19 | Eingeleitet | Wolfe Research | Outperform |
| 2019-06-11 | Fortgesetzt | Barclays | Overweight |
| 2019-05-13 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2019-03-20 | Eingeleitet | SunTrust | Buy |
| 2019-01-02 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2018-11-05 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2018-09-13 | Hochstufung | Piper Jaffray | Underweight → Neutral |
Alle ansehen
Bausch Health Companies Inc Aktie (BHC) Neueste Nachrichten
Will Bausch Health Companies Inc. stock gain from green policiesWeekly Gains Summary & Entry Point Strategy Guides - ulpravda.ru
Is Bausch Health Companies Inc. stock cheap by valuation metricsJuly 2025 Update & Reliable Entry Point Trade Alerts - ulpravda.ru
Why Bausch Health Companies Stock Rocketed 11% Higher Today - MSN
Bausch Health: Solta’s Global Expansion Playbook Is Working—But Can China’s Slowdown Be Offset? - Smartkarma
Is Bausch Health Companies Inc. (BVF) stock a defensive play amid uncertaintyTreasury Yields & Daily Oversold Bounce Ideas - ulpravda.ru
Is Bausch Health Companies Inc. stock a safe haven assetGDP Growth & Fast Exit Strategy with Risk Control - ulpravda.ru
Will Bausch Health Companies Inc. stock continue dividend increasesJuly 2025 Institutional & Verified Technical Trade Signals - ulpravda.ru
Will Bausch Health Companies Inc. stock split again soonVolume Spike & Short-Term Trading Opportunity Alerts - ulpravda.ru
Why Bausch Health Companies Inc. stock is in analyst buy zoneRecession Risk & Free Safe Entry Trade Signal Reports - ulpravda.ru
Analysis Recap: Is Bausch Health Companies Inc. stock a safe haven assetJuly 2025 Outlook & Weekly Watchlist for Consistent Profits - ulpravda.ru
Eye Health Supplements Market 2026 Forecast: In-Depth Industry - openPR.com
Bausch Health Companies Inc. Common Stock (TSX: BHC - FinancialContent
Rally Mode: Is Bausch Health Companies Inc stock a safe haven assetWeekly Market Report & Daily Entry Point Trade Alerts - moha.gov.vn
Will Bausch Health Companies Inc. stock deliver shareholder valueMomentum Trading Signals & Today’s Picks, Tomorrow’s Winners - ulpravda.ru
Does Bausch Health (BHC) Extending Secured Debt to 2032 Clarify or Complicate Its Deleveraging Path? - simplywall.st
Bausch Health Companies Inc. (BHC) Stock Analysis: A Closer Look at Its Potential in the Healthcare Sector - DirectorsTalk Interviews
A Look At Bausch Health (BHC) Valuation After Its US$1.6b Debt Refinancing - Sahm
Rosacea Market Research and Forecast Report 2025-2035: Galderma, AbbVie, Bausch Health, Journey Medical, and Sol-Gel Drive Innovation Through Expanded R&D and Clinical TrialsResearchAndMarkets.com - The AI Journal
Bausch Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference - The Globe and Mail
Trade Recap: Is Bausch Health Companies Inc stock overvalued by current metricsJuly 2025 EndofMonth & Verified Entry Point Signals - moha.gov.vn
Bausch Health Stock Pops After-Hours On Q4 Earnings Beat, Bullish Outlook: Retail Confidence Rises - MSN
Bausch Health (NYSE: BHC) unit revises $2.8B term loans, extends 2028 debt to 2031 - Stock Titan
Bausch Health (BHC) director John Paulson discloses RSUs and large shareholdings - Stock Titan
Bausch Health (BHC) director reports 4,586 RSUs and 38,408 shares owned - Stock Titan
Bausch Health (BHC) director granted 989 RSUs as quarterly board compensation - Stock Titan
Looking Into Bausch Health Companies Inc's Recent Short Interest - Benzinga
Japan Dermatology Devices Market is Driven by Skin Health - openPR.com
Bausch Health Signs Multiple Material Agreements - TradingView — Track All Markets
Bausch Health (NYSE: BHC) swaps into $1.6B 10% 2032 secured notes - Stock Titan
BHC SEC FilingsBausch Health Companies Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Q2 EPS Estimate for Bausch Health Cos Boosted by Analyst - MarketBeat
What is Zacks Research's Estimate for TSE:BHC Q4 Earnings? - MarketBeat
Bausch Health (BHC) Is Up 5.3% After US$1.6 Billion Debt ExchangeHas The Bull Case Changed? - Yahoo Finance
Bausch Health announces completion of $1.6 billion debt exchange offer By Investing.com - Investing.com Nigeria
Bausch Health announces completion of $1.6 billion debt exchange offer - Investing.com
Bausch Health Announces Final Results and Expiration of Exchange Offers - ACCESS Newswire
Bausch Health Companies Inc Announces Final Results of Exchange Offers - TradingView — Track All Markets
Bausch Health Cos (NYSE:BHC) Trading Up 4.9%Time to Buy? - MarketBeat
Beauty Devices Markets, Competition and Regional Analysis - GlobeNewswire
Beauty Devices Markets, Competition and Regional Analysis (2025-2032) Featuring Alma Lasers, Bausch Health, BRAUN, Conair, Cutera, FOREO and More - Yahoo Finance
Bausch Health’s Large 2032 Debt Exchange Might Change The Case For Investing In Bausch Health (BHC) - simplywall.st
Is Bausch Health Companies Inc. (BVF) stock dividend growth reliableBear Alert & Daily Profit Maximizing Trade Tips - ulpravda.ru
Bausch Health (NYSE:BHC) Valuation Check After Strong Early Uptake of New 2032 Note Exchange Offer - Sahm
Is Bausch Health a Contrarian Opportunity After Its Recent Price Rebound and DCF Valuation Gap - Sahm
How Bausch Health Companies Inc. stock performs in rising dollar environmentWeekly Stock Recap & Daily Entry Point Trade Alerts - Улправда
How Bausch Health Companies Inc. stock expands through international marketsJuly 2025 Pullbacks & Low Risk Investment Opportunities - DonanımHaber
Bausch + Lomb appoints two new directors to board effective January By Investing.com - Investing.com Nigeria
Bausch + Lomb appoints two new directors to board effective January - Investing.com
Bausch Health Companies (TSE:BHC) Raised to "Hold" at Raymond James Financial - MarketBeat
Bausch Health Cos Inc. (NYSE:BHC) Receives Average Rating of "Hold" from Analysts - MarketBeat
Bausch Health Cos (NYSE:BHC) Raised to Hold at Raymond James Financial - MarketBeat
Finanzdaten der Bausch Health Companies Inc-Aktie (BHC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.37%
1.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):